Literature DB >> 22717980

Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.

Hirotaka Ohara1, Kazuichi Okazaki, Hirohito Tsubouchi, Kazuo Inui, Shigeyuki Kawa, Terumi Kamisawa, Susumu Tazuma, Kazushige Uchida, Kenji Hirano, Hitoshi Yoshida, Takayoshi Nishino, Shigeru B H Ko, Nobumasa Mizuno, Hideaki Hamano, Atsushi Kanno, Kenji Notohara, Osamu Hasebe, Takahiro Nakazawa, Yasuni Nakanuma, Hajime Takikawa.   

Abstract

BACKGROUND: IgG4-sclerosing cholangitis (IgG4-SC) patients have an increased level of serum IgG4, dense infiltration of IgG4-positive plasma cells with extensive fibrosis in the bile duct wall, and a good response to steroid therapy. However, it is not easy to distinguish IgG4-SC from primary sclerosing cholangitis, pancreatic cancer, and cholangiocarcinoma on the basis of cholangiographic findings alone because various cholangiographic features of IgG4-SC are similar to those of the above progressive or malignant diseases.
METHODS: The Research Committee of IgG4-related Diseases and the Research Committee of Intractable Diseases of Liver and Biliary Tract in association with the Ministry of Health, Labor and Welfare, Japan and the Japan Biliary Association have set up a working group consisting of researchers specializing in IgG4-SC, and established the new clinical diagnostic criteria of IgG4-SC 2012.
RESULTS: The diagnosis of IgG4-SC is based on the combination of the following 4 criteria: (1) characteristic biliary imaging findings, (2) elevation of serum IgG4 concentrations, (3) the coexistence of IgG4-related diseases except those of the biliary tract, and (4) characteristic histopathological features. Furthermore, the effectiveness of steroid therapy is an optional extra diagnostic criterion to confirm accurate diagnosis of IgG4-SC.
CONCLUSION: These diagnostic criteria for IgG4-SC are useful in practice for general physicians and other nonspecialists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22717980     DOI: 10.1007/s00534-012-0521-y

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  91 in total

Review 1.  Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Yasuhisa Shinomura
Journal:  Nat Rev Rheumatol       Date:  2013-12-03       Impact factor: 20.543

Review 2.  Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.

Authors:  Hiep Nguyen Canh; Kenichi Harada
Journal:  Med Mol Morphol       Date:  2016-06-27       Impact factor: 2.309

3.  Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment.

Authors:  Kazuichi Okazaki
Journal:  Dig Dis Sci       Date:  2019-09       Impact factor: 3.199

4.  First case of IgG4-related sclerosing cholangitis associated with autoimmune hemolytic anemia.

Authors:  Hironori Masutani; Kosuke Okuwaki; Mitsuhiro Kida; Hiroshi Yamauchi; Hiroshi Imaizumi; Shiro Miyazawa; Tomohisa Iwai; Miyoko Takezawa; Wasaburo Koizumi
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  Isolated intrapancreatic IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Yushi Ikeda; Yoshiaki Kawaguchi; Hirohisa Kitagawa; Hiroki Takada; Yutaka Takeda; Isamu Makino; Naohiko Makino; Itaru Naitoh; Atsushi Tanaka
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 6.  Diagnosis and management of IgG4-related disease.

Authors:  Vinod S Hegade; Maria B Sheridan; Matthew T Huggett
Journal:  Frontline Gastroenterol       Date:  2018-10-31

7.  The 2016 diagnostic criteria for primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Kenji Notohara; Susumu Tazuma; Atsushi Tanaka; Hiroyuki Isayama; Toshio Tsuyuguchi; Toshiyuki Mori; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2016-12-05       Impact factor: 7.527

8.  Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife.

Authors:  Monica M Dua; Motaz Qadan; Glen A Lutchman; Walter G Park; George Triadafilopoulos; Brendan C Visser
Journal:  Dig Dis Sci       Date:  2014-08-20       Impact factor: 3.199

Review 9.  Diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Simizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 10.  IgG4-related hepatobiliary disease: an overview.

Authors:  Emma L Culver; Roger W Chapman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.